Showing posts with label New Mexico Board of Pharmacy. Show all posts
Showing posts with label New Mexico Board of Pharmacy. Show all posts

Sunday, March 24, 2013

New Mexico Board of Pharmacy Agenda of April Meeting Posted--Considering Removing Office Use

http://www.rld.state.nm.us/boards/Pharmacy_Members_and_Meetings.aspx


d. 16.19.30 NMAC Compounding of Non-Sterile Pharmaceuticals
Remove section on compounding for practitioner’s office use
Proposed changes/additions are underlined. Proposed deletions are struck through. Public and professional comments are welcome. Please submit comments to the board through written correspondence within 15 days before the board meeting, fax number 505-222-9845, email Larry.Loring@state.nm.us or mail to 5200 Oakland Ave. NE Suite A, Albuquerque, NM 87113.
Interested persons may testify in person at the rule hearing. Please bring at least 15 copies of any handout you wish to distribute to the board.

To view complete April agenda click here

Thursday, February 7, 2013

NMBOP Pharmacy Law Update




Date:Friday, February 08, 2013
Time:9:00 AM
Location:NMBOP Office
5200 Oakland Ave NE Suite A
Albuquerque New Mexico
87113
Tags:
back

New Mexico Board of Pharmacy Notice to Non-Resident Pharmacies Licensed within State


New Mexico Regulation and Licensing Department
BOARDS AND COMMISSIONS DIVISION
Board of Pharmacy
5200 Oakland Avenue, NE ▪ Sui te A ▪ Albuquerque, New Mexico 87113
(505) 222-9830 ▪ F a x ( 5 0 5 ) 222-9845 ▪ (800) 565-9102
www. r ld.state.nm.us/boards/Pharmacy.aspx
January 28, 2013
To: Non-resident pharmacies licensed with the NM Board of Pharmacy
Re: Required licensure/registration and standard of operation
Recent outbreaks of infections linked to contaminated injectable products made
and distributed by non-FDA registered entities have increased awareness of this
issue and the importance of its prevention. In the interest of public health and
safety, this letter is to provide information regarding FDA and NM Board of
Pharmacy registration requirements as determined by pharmaceutical
compounding activities, and required standard of operation.
Simply stated, a pharmacy may compound a patient-specific sterile product
pursuant to a prescription or order for an individual patient. Unless otherwise
exempt {21CFR207.10}, preparation of non-patient specific compounded
sterile product is considered manufacturing, and requires registration with the
FDA and the NM Board of Pharmacy as a wholesaler/distributor. The required
standard of operation for preparation of compounded sterile products is

compliance with USP <797>.
Respectfully,
Larry Loring,
Executive Director/Chief Inspector
New Mexico Board of Pharmacy

Saturday, September 8, 2012

New Mexico Board of Pharmacy is Considering Amendment to Dangerous Veterinary Drugs-Retail Distribution

During the August 27, 2012, New Mexico Board of Pharmacy meeting, the board considered an amendment to 16.19.15 regarding Dispensing Dangerous Veterinary Drugs-Retail Distribution.  The minutes to that meetings can be viewed here.  The red lined version of the amendment can be viewed here.